<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00763724</url>
  </required_header>
  <id_info>
    <org_study_id>12016</org_study_id>
    <secondary_id>F1J-MC-B027</secondary_id>
    <nct_id>NCT00763724</nct_id>
  </id_info>
  <brief_title>Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults</brief_title>
  <official_title>A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to estimate the incidence of suicide attempts resulting
      in a medical encounter or hospitalization in seven propensity matched cohorts of subjects:
      patients treated with duloxetine for depression, patients treated with one of three other
      antidepressants or antidepressant classes (venlafaxine, SSRIs, or TCAs) for depression,
      patients treated with multiple antidepressants for depression (either concurrently or
      consecutively), depressed patients with no pharmacologic treatment, and a non-depressed
      general population sample.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of suicide attempt resulting in medical encounter or hospitalization.</measure>
    <time_frame>Endpoint</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relative risk of suicide attempt resulting in medical encounters or hospitalization</measure>
    <time_frame>Endpoint</time_frame>
  </secondary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Actual">254432</enrollment>
  <condition>Depression</condition>
  <condition>Suicide</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Duloxetine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Venlafaxine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>SSRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>TCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>Multiple Antidepressants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <description>Depressed (not antidepressant treated)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <description>General population</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be based on data from the PharMetrics Patient-Centric Database, a
        commercially available claims database provided by PharMetrics, Inc., a Unit of IMS.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older at index date

          -  Have at least 6 months of continuous enrollment data prior to index date.

          -  Have complete medical, facility, and pharmacy records (the latter of which will
             include complete quantity and days supplied information).

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Call 1-877-CTLILLY (1-877-285-4559) or 317-615-4559 Mon-Fri 9am - 5pm Eastern time (UTC/GMT - 5 hours, EST)</last_name>
    <role>Study Director</role>
    <affiliation>Eli Lilly and Company</affiliation>
  </overall_official>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2008</study_first_submitted>
  <study_first_submitted_qc>September 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2008</study_first_posted>
  <last_update_submitted>March 9, 2010</last_update_submitted>
  <last_update_submitted_qc>March 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Chief Medical Officer</name_title>
    <organization>Eli Lilly</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
    <mesh_term>Suicide, Attempted</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

